The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation

Roberto, A; Di Vito, C; Zaghi, E; Mazza, E M C; Capucetti, A; Calvi, M; Tentorio, P; Zanon, V; Sarina, B; Mariotti, J; Bramanti, S; Tenedini, E; Tagliafico, E; Bicciato, S; Santoro, A; Roederer, M; Marcenaro, E; Castagna, L; Lugli, E; Mavillo, D